할인방
Clinics- 저널 단행본
디지털, 인공지능의학
동물보건사
한글도서 기초
한글도서 내과
한글도서 외과
한글도서 영상/안과/치과
한글도서 기타
기초 생명의과학
실험동물
수의 윤리/복지
기생충/산과/유전
공중보건/전염병학
독성/약리,약전
면역/미생물학
발생/해부/생리학
조직/병리학
수생동물
조류
산업/중,대동물
돼지
말
소
고양이
동물 보정,핸들링
수의 일반/기타 참고도서
소동물 내과
소동물 외과
재활/신경, 정형외과학
내시경, 자령/노령동물학
비뇨기/이비인후과
마취,통증/응급,수액
소화/영양/피부학
내분비/신경/행동학
심장,호흡기/종양학
안과/치과학
영상진단의학
임상병리(세포,혈액학)
대체의학(침술,허브)
야생/특수동물 Exo, Zoo
종보존/동물보호/법의학
병원경영/사전/용어
BSAVA 시리즈
자유결제
100자 서평
질문과 대답
  T: 042-330-0039

  042-361-2500

  HP: 010-8364-0400

  F: 042-367-1017

평일 10:00 ~ 18:00


이메일문의
신한 100-023-144280
국민 732801-01-097961
농협 453131-56-197831
하나 660-910336-13307
예금주: 이상돈 okvet
 
 
비밀번호 확인 닫기
공중보건/전염병학 > 공중보건 > Vaccinology and Methods in Vaccine Research, 1st Edition - 신간POD상품

 
Vaccinology and Methods in Vaccine Research, 1st Edition - 신간POD상품
상품명 : Vaccinology and Methods in Vaccine Research, 1st Edition - 신간POD상품
제조회사 : Academic Press
원산지 : USA
적립금액 : 6,420원
소비자가 : 214,000원
판매가격 : 214,000원
수량 EA
 
배송조건 : (조건)
   
 

Vaccinology and Methods in Vaccine Research, 1st Edition





신간POD(Printed On Demand/주문형서적) 상품 안내

이 도서는 신간POD상품입니다.
신간POD: 신간도서이나 출판사의 물류비 절감을 위해 주문시마다 제작하는 도서
            POD도서의 특성상 책의 형태로 인쇄하고 제본한 결과물이 정상 출간된 도서에 비해 퀄리티가 떨어질 수 있습니다.






No. of pages: 336
Published: March 10, 2022
Imprint: Academic Press
Paperback ISBN: 9780323911467



Description


Vaccinology and Methods in Vaccine Research is a combination of cutting-edge methodologies, experimental approaches and literature reviews. The book covers all aspects of vaccine development, including basic immunology (focusing on the stimulation of adaptive immunity, which is required for vaccine efficacy), approaches to vaccine design and target validation, vaccine biomanufacturer and clinical development. Existing vaccinology resources are theoretical reference books, whereas this book provides a practical handbook for use in the research lab and classroom by those working in vaccinology and training others in the field. It is authored and edited by scientists actively engaged in vaccine research and development for day-to-day teaching/methodological advice.



Key Features


  • Addresses how to design a vaccine for an emerging disease, from a practical point-of -view, with chapters written by scientists who are grappling with these questions
  • Provides new approaches to vaccine development. including vaccine targeting and virus-like-particle vaccines
  • Gives up-to-date information and methodologies in use for vaccine adjuvants



    • Readership


    Academic faculties, researchers, students and scientists in the field of immunology, pharmacology and vaccinology; Academics researching and developing vaccines (from graduate students to group leaders)



    Table of Contents


  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • List of contributors
  • Preface
  • Acknowledgements
  • Chapter 1. Immunology and the concept of vaccination
  • Abstract
  • Manipulation of the immune system by vaccination
  • Overview of immunity and the immune system
  • Prophylactic and therapeutic vaccines
  • References
  • Chapter 2. Vaccine types and reverse vaccinology
  • Abstract
  • Introduction
  • Fundamentals of vaccine immunology
  • Classes of vaccines
  • Immunoinformatics
  • References
  • Chapter 3. Dendritic cells as vaccine targets
  • Abstract
  • Introduction to dendritic cells
  • Origin and types of dendritic cells
  • Location of dendritic cells
  • Receptors of dendritic cells
  • References
  • Further reading
  • Chapter 4. Vaccine development: from the laboratory to the field
  • Abstract
  • Introduction
  • Antigen selection for new vaccines
  • Genetic studies
  • Basic protein studies
  • Other methods of in vitro evaluation of immunogenicity
  • Conclusion
  • References
  • Further reading
  • Chapter 5. Harnessing the power of CD8+ T-cells: identification and validation of peptides bound to major histocompatibility complex class I by immunopeptidomics
  • Abstract
  • CD8+ T cells and major histocompatibility complex class I antigen presentation
  • Proteasome cleavage mechanisms
  • Intracellular trafficking of peptides
  • Peptide binding affinity to major histocompatibility complex class I
  • Tools for discovering immunogenic peptides
  • Immunopeptidomics
  • Vaccine design based on immunopeptidomics
  • Methods for the validation of immunogenic peptides
  • Conclusions
  • Acknowledgments
  • References
  • Chapter 6. Virus-like particle vaccines
  • Abstract
  • Introduction
  • Immune response to virus-like particles
  • Production of virus-like particles
  • Expression systems
  • Manufacturing: upstream process
  • Manufacturing: purification of virus-like particles (downstream process)
  • Major contaminants and removal strategies
  • Analytical tools for virus-like particles
  • Conclusion
  • References
  • Chapter 7. Approaches to cancer vaccination
  • Abstract
  • Introduction
  • Types of cancer vaccines
  • Novel trends in cancer vaccine development
  • Cancer vaccine delivery systems
  • Summary
  • References
  • Chapter 8. Vaccines against SARS-CoV-2
  • Abstract
  • The COVID-19 pandemic
  • The spike protein of the SARS-CoV-2 virus
  • COVID-19 vaccine development
  • Nucleic acid–based vaccines
  • Viral vector vaccines
  • Antigen-presenting cell-based vaccines
  • Whole organism-based vaccines
  • Future vaccine requirements and challenges
  • References
  • Chapter 9. Adjuvants, immunomodulators, and adaptogens
  • Abstract
  • Introduction
  • Aluminum-based adjuvants
  • Emulsion-based adjuvants
  • Saponins
  • Immune stimulating complexes
  • TLR agonists
  • Nanoparticles
  • Liposomes
  • Exosomes
  • GSK adjuvant systems
  • Cholera toxin
  • Freund’s adjuvant
  • α-GalCer
  • Adjuvant properties of the microbiome
  • Plant-derived adaptogens
  • References
  • Chapter 10. GMP manufacture and quality control
  • Abstract
  • Introduction
  • Regulation
  • GMP manufacture
  • Vaccine purification
  • In process controls and final release testing
  • References
  • Chapter 11. Testing vaccines: essential steps in clinical trial design
  • Abstract
  • Introduction
  • Vaccine development pathway
  • Introduction to good clinical practice
  • Consent
  • Good clinical practice compliant documentation
  • Clinical trial roles and responsibilities
  • Ensuring quality
  • Safety
  • Adverse events
  • Other trial considerations
  • Final word
  • References
  • Index



    • About the Editors


    Rebecca Ashfield

    Rebecca Ashfield Jenner Institute, University of Oxford (ORCRB Roosevelt Drive Oxford OX3 7DQ). BA (1st class) Oxford, DPhil Oxford, over 20 years working in field of immunotherapy and vaccine development. Currently CSO of Ducentis Biotherapeutics Ltd and Senior Project Manager at the Jenner Institute. Organiser/co-leader of several vaccinology courses in Oxford and Leiden. Edited most recent Jenner Institute triennial report. Expertise in vaccine GMP manufacture, led successful application to Innovate UK for £75M vaccine innovation and manufacturing centre, currently being built at Harwell in Oxfordshire. H=20

    Affiliations and Expertise

    Currently CSO of Ducentis Biotherapeutics Ltd and Senior Project Manager, Jenner Institute, University of Oxford, UK

    Angus Oli

    Angus Nnamdi Oli Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus (Post code 422001, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil NAU and a DPharm. University of Benin, Nigeria. Currently a Senior Lecturer with over 8 years’ experience. Author of several articles in peer-reviewed journals indexed in Pubmed, Web of Science and Scopus. Current research interests/career goals are Infection and immunology of infectious diseases with emphasis of viral and bacterial infections, development of effective vaccines with strong antibody and T lymphocytes effect or responses against the infections, Pharmaceutical Quality Systems and Clinical vaccinology. H: 5

    Affiliations and Expertise

    Senior Lecturer, Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus, Agulu, Anambra State, Nigeria

    Charles Esimone

    Charles Okechukwu Esimone Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU, Main Campus, PMB 5025, Awka, Anambra State, Nigeria). BPharm., MPharm. and PhD in Pharmaceutics, University of Nigeria, Nsukka (UNN). With over 20 years’ experience as a lecturer and research scientist and over 12 years’ experience in vaccinology/immunology research. Currently a Professor and VC of Nnamdi Azikiwe University, Editor-in-Chief of the Journal of Current Biomedical Research and the Biomedical Research Committee, currently chaired by me, focuses on the development of biotechnological products such as vaccines for tropical diseases, amongst other interest. H: 18

    Affiliations and Expertise

    Lecturer and Senior Scientist, Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU, Main Campus, PMB 5025, Awka, Anambra State, Nigeria). BPharm., MPharm. and PhD in Pharmaceutics, University of Nigeria, Nsukka (UNN), Nigeria

    Linda Anagu

    Linda Onyeka Anagu Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus (Post code 422001, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil Keele University. With over 8 years’ experience as a lecturer and research scientist. She has interest in vaccine design/development processes that borders on her expertise in molecular cloning and Plasmodium epigenetics. Recently, attended the Vaccinology Summer School organized by Dr. Rebecca Ashfield and the late Dr. Sahid Khan in Leiden. Edited the recent, 2015 edition of LABORATORY HANDBOOK OF PHARMACEUTICAL MICROBIOLOGY AND BIOTECHNOLOGY, used by undergraduate and postgraduate students at Nnamdi Azikiwe University. ERC H: 5

    Affiliations and Expertise

    Lecturer and Research Scientist, Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University (NAU), Agulu Campus, Agulu, Anambra State, Nigeria). BPharm. and MPharm. UNN, DPhil Keele University, Nigeria
     
     
     
     
    상호명 : OKVET 사업자등록번호 : 314-90-93001 314-90-93001 통신판매업신고번호 : 유성구청 제2006-75호
    [이용약관] [개인정보 처리방침] 개인정보 보호 책임자 : 이상돈 대표 : 이상돈
    사업장소재지 : 대전광역시 유성구 테크노3로 65, 한신 S-MECA 440호
    Copyright ⓒ okvet All Rights Reserved. T: 042-330-0039, 042-361-2500, HP: 010-8364-0400, F: 042-367-1017